Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-15

Clinical Trial Update: Inspiris Resilia Durability Registry

View source ↗

Summary

A registry update for the Inspiris Resilia Dur durability Registry assessing outcomes in patients with aortic valve disease; the study is currently ACTIVE_NOT_R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inspiris Resilia Transcatheter Heart Valve (transcatheter heart valve)

Snippet

Sponsor: Institut für Pharmakologie und Präventive Medizin | Conditions: Aortic Valve Stenosis | Status: ACTIVE_NOT_RECRUITING